F. M. Berger
Impact in
- Psychiatry and Mental health top 10%
- Epilepsy research and treatment
- Dementia and Cognitive Impairment Research
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Peroxisome Proliferator-Activated Receptors 3
- Co-authors
- B. J. Ludwig (15 shared papers)M. Kletzkin (8 shared papers)Lutz Frölich (6 shared papers)J. F. Douglas (8 shared papers)S. Margolin (10 shared papers)J. P. Rosselet (3 shared papers)Charles D. Hendley (2 shared papers)Pasquale Calabrese (2 shared papers)
- Journals
- Experimental Biology and Medicine (12 papers)Journal of Pharmacology and Experimental Therapeutics (8 papers)Clinical Pharmacology & Therapeutics (5 papers)Journal of Medicinal Chemistry (3 papers)European Neuropsychopharmacology (3 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
F. M. Berger
65 papers receiving 505 citations
Peers
Comparison fields: 5 of 113
- Psychiatry and Mental health 107
- Pharmacology 50
- Cellular and Molecular Neuroscience 84
- Pharmacology 72
- Toxicology 14
Countries citing papers authored by F. M. Berger
This map shows the geographic impact of F. M. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. M. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. M. Berger more than expected).
Fields of papers citing papers by F. M. Berger
This network shows the impact of papers produced by F. M. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. M. Berger. The network helps show where F. M. Berger may publish in the future.
Co-authors
The 25 scholars most cited alongside F. M. Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1954 | 115 | |
| 2 | 1957 | 60 | |
| 3 | 1989 | 25 | |
| 4 | 1969 | 24 | |
| 5 | 1969 | 21 | |
| 6 | 1963 | 20 | |
| 7 | 1952 | 19 | |
| 8 | 2000 | 19 | |
| 9 | 1961 | 19 | |
| 10 | 1967 | 18 | |
| 11 | 1975 | 17 | |
| 12 | 2003 | 16 | |
| 13 | Unusual muscle relaxant and analgesic properties of N-isopropyl-2-propyl-1,3-propanediol dicarbamate (carisoprodol). | 1959 | 15 |
| 14 | 1959 | 14 | |
| 15 | 1956 | 14 | |
| 16 | 1967 | 13 | |
| 17 | 1963 | 12 | |
| 18 | 1961 | 12 | |
| 19 | 1974 | 11 | |
| 20 | 1969 | 10 |
About F. M. Berger
F. M. Berger is a scholar working on Organic Chemistry, Molecular Biology, Pharmacology, Cellular and Molecular Neuroscience and Psychiatry and Mental health, having authored 69 papers that have together received 642 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (8 papers), Immune Response and Inflammation (5 papers), Dementia and Cognitive Impairment Research (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Epilepsy research and treatment (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Treatment of Major Depression (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Psychiatry and Mental health (107 citations), Pharmacology (50 citations), Cellular and Molecular Neuroscience (84 citations), Pharmacology (72 citations) and Toxicology (14 citations). F. M. Berger has collaborated with scholars based in United States, Germany and France. Frequent co-authors include B. J. Ludwig, M. Kletzkin, Lutz Frölich, J. F. Douglas, S. Margolin, J. P. Rosselet, Charles D. Hendley, Pasquale Calabrese, J.L. Touraine and Claus Göbel. Their work appears in journals such as Experimental Biology and Medicine, Journal of Pharmacology and Experimental Therapeutics, Clinical Pharmacology & Therapeutics, Journal of Medicinal Chemistry and European Neuropsychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.